首页 > 市场调查报告书 > 製药

市场调查报告书

商品编码

1624062

脱髮症市场规模、份额和增长分析（按疾病类型、治疗方法、性别、销售管道、最终用途和地区）：行业预测（2025-2032）

Alopecia Market Size, Share, Growth Analysis, By Disease type (Alopecia Areata, Cicatricial), By Treatment (Pharmaceuticals, Devices), By Gender, By Sales Channel, By End Use, By Region - Industry Forecast 2025-2032

出版日期: 2025年01月01日 | 出版商:

SkyQuest | 英文 165 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2023年全球脱髮症市场规模预计为87.1亿美元，预测期内（2025-2032年）复合年增长率为8.0%，从2024年的94.1亿美元增至2032年的17.4亿美元。 1000万美元。

由于消费者对功效更高、副作用最小的先进毛髮修復药物的需求不断增加，脱髮症治疗市场正在显着增长。细胞激素疗法和再生细胞疗法等着名的新治疗方法因其透过促进细胞特化和控制毛髮生长週期来促进毛髮生长的能力而越来越受欢迎。此外，联合治疗已被证明有效，目前受到消费者的青睐。市场预计将出现创新解决方案，包括多功能成分和促进毛髮生长的先进疗法，例如干细胞疗法和低强度雷射疗法。市场规模预计将从2024年的94.5亿美元扩大到2032年的181.8亿美元，预计脱髮症领域将在雷射帽和头盔等创新产品的推动下强劲扩张。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东/非洲
- 海湾合作委员会国家
- 南非
- 其他中东/非洲

竞争格局

前5名企业对比
主要企业市场定位（2024年）
主要企业采取的策略
近期市场趋势
主要企业市场占有率（2024年）
主要企业简介
- 公司简介
- 产品系列分析
- 按细分市场分類的份额分析
- 收益与前一年同期比较（2022-2024）

主要企业简介

Johnson & Johnson
Merck & Co.
Pfizer Inc.
Cipla Limited
Dr. Reddy's Laboratories Ltd.
Sun Pharmaceutical Industries Ltd.
GlaxoSmithKline plc
Aclaris Therapeutics, Inc.
Concert Pharmaceuticals, Inc.
HCell Inc.
Follica, Inc.
Histogen Inc.
Allergan plc
Bayer AG
Kythera Biopharmaceuticals, Inc.
Polichem SA
Takeda Pharmaceutical Company Limited
Almirall, SA
Perrigo Company plc
Vegalab, Inc.

结论和建议

简介目录

Product Code: SQSG35I2021

Global Alopecia Market size was valued at USD 8.71 billion in 2023 and is poised to grow from USD 9.41 billion in 2024 to USD 17.41 billion by 2032, growing at a CAGR of 8.0% during the forecast period (2025-2032).

The alopecia treatment market is experiencing significant growth driven by increased consumer demand for advanced hair-restoration medications with improved efficacy and minimal side effects. Notable emerging therapies, such as cytokine therapy and regenerative cell therapy, are gaining traction for their ability to enhance hair regrowth by promoting cellular specialization and regulating the hair growth cycle. Additionally, combination therapies have proven effective and are currently the preferred choice among consumers. The market is expected to see innovative solutions, including multifunctional ingredients and advanced treatments like stem cell therapy and low-level laser therapy, which are enhancing hair regrowth. With a projected market size increase from USD 9.45 Billion in 2024 to USD 18.18 Billion by 2032, the alopecia sector is set for robust expansion, marked by innovative products like laser caps and helmets.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Alopecia market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Alopecia Market Segmental Analysis

Global Alopecia Market is segmented by Disease type, Treatment, Gender, Sales Channel, End Use and region. Based on Disease type, the market is segmented into Alopecia Areata, Cicatricial, Traction and Androgenetic Alopecia. Based on Treatment, the market is segmented into Pharmaceuticals and Devices. Based on Gender, the market is segmented into Male and Female. Based on Sales Channel, the market is segmented into Prescriptions and OTC. Based on End Use, the market is segmented into Homecare setting and Dermatology clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Alopecia Market

The global alopecia market is poised for expansion, driven by the increasing prevalence of hair loss conditions. The American Academy of Dermatology Association (AAD) reported that in 2021, approximately 30 million women and 50 million men in the U.S. were affected by alopecia. Notably, around 60% of individuals experience some degree of hair thinning, with pattern hair loss being the most widespread form among both sexes, according to the Journal of Clinical and Diagnostic Research (JCDR). Furthermore, research indicates that 2% of the general population will experience alopecia areata in their lifetime. The rising costs associated with healthcare are propelling the alopecia market forward, particularly due to initiatives from organizations like the American Hair Loss Association and the National Alopecia Areata Foundation, which focus on educating the public about treatment options and hair regrowth strategies. Alopecia areata, like many autoimmune disorders, may have hereditary factors and unknown triggers linked to hair loss. Conditions such as multiple sclerosis, type 1 diabetes, and other autoimmune diseases have shown connections to increased risks for alopecia, further emphasizing the need for awareness and treatment. As public and private campaigns continue to promote awareness and education on alopecia, coupled with the growing statistics on autoimmune diseases and lifestyle factors, the global alopecia market will likely see substantial growth in the coming years.

Restraints in the Global Alopecia Market

The growth of the global alopecia market faces several challenges that may hinder its expansion. One significant restraint is the high cost associated with treatments, which can deter potential consumers. Additionally, in emerging countries, the market will confront obstacles due to inadequate primary care services and insufficient healthcare infrastructure. Furthermore, from 2022 to 2028, stringent regulatory frameworks and low public awareness regarding alopecia and its treatments will further constrain market growth. These factors combined create a challenging environment that could impede the overall advancement of the alopecia market in the coming years.

Market Trends of the Global Alopecia Market

The Global Alopecia market is poised for significant growth, driven by rising incidences of chronic conditions such as arthritis, PCOS, and cancer, along with lifestyle changes and heightened stress levels among populations. The increasing prevalence of hormonal imbalances and unhealthy dietary habits has further fueled demand for effective alopecia treatments, including medications and surgical procedures like hair transplantation. Additionally, an aging population emphasizes the need for targeted solutions in this sector. With substantial market potential in emerging regions, innovative treatment options are expected to shape growth trends, offering lucrative opportunities for stakeholders in the forthcoming years.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technology Analysis
Regulatory Analysis
Patent Analysis
Case Studies

Global Alopecia Market Size by Disease type & CAGR (2025-2032)

Market Overview
Alopecia Areata
Cicatricial
Traction
Androgenetic Alopecia

Global Alopecia Market Size by Treatment & CAGR (2025-2032)

Market Overview
Pharmaceuticals
Devices

Global Alopecia Market Size by Gender & CAGR (2025-2032)

Market Overview
Male
Female

Global Alopecia Market Size by Sales Channel & CAGR (2025-2032)

Market Overview
Prescriptions
OTC

Global Alopecia Market Size by End Use & CAGR (2025-2032)

Market Overview
Homecare setting
Dermatology clinics

Global Alopecia Market Size & CAGR (2025-2032)

North America (Disease type, Treatment, Gender, Sales Channel, End Use)
- US
- Canada
Europe (Disease type, Treatment, Gender, Sales Channel, End Use)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Disease type, Treatment, Gender, Sales Channel, End Use)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Disease type, Treatment, Gender, Sales Channel, End Use)
- Brazil
- Rest of Latin America
Middle East & Africa (Disease type, Treatment, Gender, Sales Channel, End Use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Johnson & Johnson
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck & Co.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cipla Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dr. Reddy's Laboratories Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sun Pharmaceutical Industries Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlaxoSmithKline plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aclaris Therapeutics, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Concert Pharmaceuticals, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
HCell Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Follica, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Histogen Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Allergan plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bayer AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kythera Biopharmaceuticals, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Polichem S.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takeda Pharmaceutical Company Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Almirall, S.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Perrigo Company plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vegalab, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments